HIV replication: A game of hide and sense

Current Opinion in HIV and AIDS

Volumn 11, Issue 2, 2016, Pages 173-181

  Sauter, Daniel ^a   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

cloaking; cyclic GMP AMP synthase; HIV; IFI16; sensing

Indexed keywords

CYTOPLASMIC RECEPTOR; NUCLEASE; TOLL LIKE RECEPTOR; MB21D1 PROTEIN, HUMAN; NUCLEOTIDYLTRANSFERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MOLECULAR SENSOR; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; REVIEW; VIRUS PATHOGENESIS; VIRUS REPLICATION; BIOLOGICAL MODEL; HOST PATHOGEN INTERACTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE EVASION; IMMUNOLOGY; PATHOGENICITY; VIROLOGY;

HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MODELS, IMMUNOLOGICAL; NUCLEOTIDYLTRANSFERASES; TOLL-LIKE RECEPTORS; VIRUS REPLICATION;

EID: 84957437097     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0000000000000233     Document Type: Review

References (104)

1. Luban J. Innate immune sensing of HIV-1 by dendritic cells. Cell Host Microbe 2012; 12: 408-418.
2. Towers GJ, Noursadeghi M. Interactions between HIV-1 and the cell-autonomous innate immune system. Cell Host Microbe 2014; 16: 10-18.
3. van Montfoort N, Olagnier D, Hiscott J. Unmasking immune sensing of retroviruses: interplay between innate sensors and host effectors. Cytokine Growth Factor Rev 2014; 25: 657-668.
4. Silvin A, Manel N. Innate immune sensing of HIV infection. Curr Opin Immunol 2015; 32: 54-60.
5. Lahaye X, Manel N. Viral and cellular mechanisms of the innate immune sensing of HIV. Curr Opin Virol 2015; 11: 55-62.
6. Jakobsen MR, Olagnier D, Hiscott J. Innate immune sensing of HIV-1 infection. Curr Opin HIV AIDS 2015; 10: 96-102.
7. Müller-Trutwin M, Hosmalin A. Role for plasmacytoid dendritic cells in anti- HIV innate immunity. Immunol Cell Biol 2005; 83: 578-583.
8. Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010; 234: 142-162.
9. Beignon A-S, McKenna K, Skoberne M, et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005; 115: 3265-3275.
10. Lepelley A, Louis S, Sourisseau M, et al. Innate sensing of HIV-infected cells. PLoS Pathog 2011; 7: e1001284.
11. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of singlestranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-1529.
12. Simmons RP, Scully EP, Groden EE, et al. HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways. AIDS Lond Engl 2013; 27: 2505-2517.
13. Meier A, Alter G, Frahm N, et al. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007; 81: 8180-8191.
14. Mandl JN, Barry AP, Vanderford TH, et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections. Nat Med 2008; 14: 1077-1087.
15. Schmidt B, Ashlock BM, Foster H, et al. HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration. Virology 2005; 343: 256-266.
16. Nazli A, Kafka JK, Ferreira VH, et al. HIV-1 gp120 induces TLR2- and TLR4- mediated innate immune activation in human female genital epithelium. J Immunol Baltim Md 19502013; 191: 4246-4258.
17. Gao D, Wu J, Wu Y-T, et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 2013; 341: 903-906.
18. Ablasser A, Goldeck M, Cavlar T, et al. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 2013; 498: 380-384.
19. Diner EJ, Burdette DL, Wilson SC, et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep 2013; 3: 1355-1361.
20. Yoh SM, Schneider M, Seifried J, et al. PQBP1 is a proximal sensor of the cGAS-dependent innate response to HIV-1. Cell 2015; 161: 1293-1305.
21. Ablasser A, Schmid-Burgk JL, Hemmerling I, et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 2013; 503: 530-534.
22. Gentili M, Kowal J, Tkach M, et al. Transmission of innate immune signaling by packaging of cGAMP in viral particles. Science 2015; 349: 1232-1236.
23. Bridgeman A, Maelfait J, Davenne T, et al. Viruses transfer the antiviral second messenger cGAMP between cells. Science 2015; 349: 1228-1232.
24. Stetson DB, Medzhitov R. Recognition of cytosolic DNA activates an IRF3- dependent innate immune response. Immunity 2006; 24: 93-103.
25. Herzner A-M, Hagmann CA, Goldeck M, et al. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nat Immunol 2015; 16: 1025-1033.
26. Unterholzner L, Keating SE, Baran M, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010; 11: 997-1004.
27. Jakobsen MR, Bak RO, Andersen A, et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad Sci U S A 2013; 110: E4571-E4580.
28. Monroe KM, Yang Z, Johnson JR, et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 2014; 343: 428-432.
29. Diamond TL, Roshal M, Jamburuthugoda VK, et al. Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem 2004; 279: 51545-51553.
30. Baldauf H-M, Pan X, Erikson E, et al. SAMHD1 restricts HIV-1 infection in resting CD4+ T cells. Nat Med 2012; 18: 1682-1689.
31. Doitsh G, Cavrois M, Lassen KG, et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010; 143: 789-801.
32. Galloway NLK, Doitsh G, Monroe KM, et al. Cell-to-cell transmission of HIV-1 is required to trigger pyroptotic death of lymphoid-tissue-derived CD4 T cells. Cell Rep 2015; 12: 1555-1563.
33. Muñoz-Arias I, Doitsh G, Yang Z, et al. Blood-derived CD4 T cells naturally resist pyroptosis during abortive HIV-1 infection. Cell Host Microbe 2015; 18: 463-470.
34. Cooper A, García M, Petrovas C, et al. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 2013; 498: 376-379.
35. Solis M, Nakhaei P, Jalalirad M, et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I. J Virol 2011; 85: 1224-1236.
36. Pertel T, Hausmann S, Morger D, et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011; 472: 361-365.
37. Galão RP, Le Tortorec A, Pickering S, et al. Innate sensing of HIV-1 assembly by tetherin induces NFkB-dependent proinflammatory responses. Cell Host Microbe 2012; 12: 633-644.
38. Galão RP, Pickering S, Curnock R, Neil SJD. Retroviral retention activates a Syk-dependent HemITAM in human tetherin. Cell Host Microbe 2014; 16: 291-303.
39. Arhel NJ, Souquere-Besse S, Munier S, et al. HIV-1 DNA Flap formation promotes uncoating of the preintegration complex at the nuclear pore. EMBO J 2007; 26: 3025-3037.
40. Lahaye X, Satoh T, Gentili M, et al. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 2013; 39: 1132-1142.
41. Rasaiyaah J, Tan CP, Fletcher AJ, et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013; 503: 402-405.
42. Manel N, Hogstad B, Wang Y, et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 2010; 467: 214-217.
43. Yan N, Regalado-Magdos AD, Stiggelbout B, et al. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 2010; 11: 1005-1013.
44. Lahouassa H, Daddacha W, Hofmann H, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol 2012; 13: 223-228.
45. Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474: 654-657.
46. Hrecka K, Hao C, Gierszewska M, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 2011; 474: 658-661.
47. St Gelais C, de Silva S, Amie SM, et al. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons. Retrovirology 2012; 9: 105.
48. White TE, Brandariz-Nuñez A, Valle-Casuso JC, et al. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation. Cell Host Microbe 2013; 13: 441-451.
49. Welbourn S, Dutta SM, Semmes OJ, Strebel K. Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1. J Virol 2013; 87: 11516-11524.
50. Ryoo J, Choi J, Oh C, et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nat Med 2014; 20: 936-941.
51. Choi J, Ryoo J, Oh C, et al. SAMHD1 specifically restricts retroviruses through its RNase activity. Retrovirology 2015; 12: 46.
52. Genovesio A, Kwon Y-J, Windisch MP, et al. Automated genome-wide visual profiling of cellular proteins involved in HIV infection. J Biomol Screen 2011; 16: 945-958.
53. Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008; 134: 587-598.
54. Zhao K, Du J, Han X, et al. Modulation of LINE-1 and Alu/SVA retrotransposition by Aicardi-Goutiè res syndrome-related SAMHD1. Cell Rep 2013; 4: 1108-1115.
55. El Hage A, Webb S, Kerr A, Tollervey D. Genome-wide distribution of RNADNA hybrids identifies RNase H targets in tRNA genes, retrotransposons and mitochondria. PLoS Genet 2014; 10: e1004716.
56. Crow YJ, Manel N. Aicardi-Goutieres syndrome and the type I interferonopathies. Nat Rev Immunol 2015; 15: 429-440.
57. Rice GI, del Toro Duany Y, Jenkinson EM, et al. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet 2014; 46: 503-509.
58. Rice GI, Kasher PR, Forte GMA, et al. Mutations in ADAR1 cause Aicardi- Goutiè res syndrome associated with a type I interferon signature. Nat Genet 2012; 44: 1243-1248.
59. Yang S, Deng P, Zhu Z, et al. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs. J Immunol Baltim Md 2014; 193: 3436-3445.
60. Mannion NM, Greenwood SM, Young R, et al. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep 2014; 9: 1482-1494.
61. Chan JK, Greene WC. Dynamic roles for NF-kB in HTLV-I and HIV-1 retroviral pathogenesis. Immunol Rev 2012; 246: 286-310.
62. Sauter D, Hotter D, Van Driessche B, et al. Differential regulation of NF-kBmediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins. Cell Rep 2015; 10: 586-599.
63. Furia B, Deng L, Wu K, et al. Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins. J Biol Chem 2002; 277: 4973-4980.
64. Razooky BS, Pai A, Aull K, et al. A hardwired HIV latency program. Cell 2015; 160: 990-1001.
65. Neil SJD, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008; 451: 425-430.
66. Van Damme N, Goff D, Katsura C, et al. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008; 3: 245-252.
67. Bour S, Perrin C, Akari H, Strebel K. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCPmediated degradation of Ikappa B. J Biol Chem 2001; 276: 15920-15928.
68. Akari H, Bour S, Kao S, et al. The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J Exp Med 2001; 194: 1299-1311.
69. Leulier F, Marchal C, Miletich I, et al. Directed expression of the HIV-1 accessory protein Vpu in Drosophila fat-body cells inhibits Toll-dependent immune responses. EMBO Rep 2003; 4: 976-981.
70. Sauter D, Schindler M, Specht A, et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 2009; 6: 409-421.
71. Sauter D, Unterweger D, Vogl M, et al. Human tetherin exerts strong selection pressure on the HIV-1 Group N Vpu protein. PLoS Pathog [Internet] 2012; 8: ; Available from: http://wwwncbinlmnihgov/pmc/articles/PMC3534379/.
72. Sauter D, Hue S, Petit SJ, et al. HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology 2011; 8: 103.
73. Yang SJ, Lopez LA, Exline CM, et al. Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology 2011; 8: 78.
74. Kluge SF, Mack K, Iyer SS, et al. Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe 2014; 16: 639-650.
75. Zhang F, Wilson SJ, Landford WC, et al. Nef proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 2009; 6: 54-67.
76. Schmkel J, Sauter D, Schindler M, et al. The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 are not always linked in primate lentiviruses. J Virol 2011; 85: 742-752.
77. Le Tortorec A, Neil SJD. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 2009; 83: 11966-11978.
78. Doehle BP, Chang K, Fleming L, et al. Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells. J Virol 2012; 86: 8499-8506.
79. Doehle BP, Chang K, Rustagi A, et al. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J Virol 2012; 86: 8367-8374.
80. Park SY, Waheed AA, Zhang Z-R, et al. HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor. J Biol Chem 2014; 289: 35102-35110.
81. Hotter D, Kirchhoff F, Sauter D. HIV-1 Vpu does not degrade interferon regulatory factor 3. J Virol 2013; 87: 7160-7165.
82. Manganaro L, de Castro E, Maestre AM, et al. HIV Vpu interferes with NF-kB activity but not with interferon regulatory factor 3. J Virol 2015; 89: 9781-9790.
83. Bego MG, Côté É , Aschman N, et al. Vpu exploits the cross-talk between BST2 and the ILT7 receptor to suppress anti-HIV-1 responses by plasmacytoid dendritic cells. PLoS Pathog 2015; 11: e1005024.
84. Schindler M, Münch J, Kutsch O, et al. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006; 125: 1055-1067.
85. Kratovac Z, Virgen CA, Bibollet-Ruche F, et al. Primate lentivirus capsid sensitivity to TRIM5 proteins. J Virol 2008; 82: 6772-6777.
86. Reuven EM, Ali M, Rotem E, et al. The HIV-1 envelope transmembrane domain binds TLR2 through a distinct dimerization motif and inhibits TLR2- mediated responses. PLoS Pathog 2014; 10: e1004248.
87. Chung NPY, Matthews K, Klasse PJ, et al. HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells. J Immunol Baltim MD 19502012; 189: 5257-5265.
88. Martinelli E, Cicala C, Van Ryk D, et al. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc Natl Acad Sci U S A 2007; 104: 3396-3401.
89. Laguette N, Brégnard C, Hue P, et al. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 2014; 156 (1-2): 134-145.
90. Lim ES, Fregoso OI, McCoy CO, et al. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 2012; 11: 194-204.
91. Etienne L, Hahn BH, Sharp PM, et al. Gene loss and adaptation to hominids underlie the ancient origin of HIV-1. Cell Host Microbe 2013; 14: 85-92.
92. Puigdomènech I, Casartelli N, Porrot F, Schwartz O. SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocytederived dendritic cells. J Virol 2013; 87: 2846-2856.
93. van der Ende ME, Schutten M, Ly TD, et al. HIV-2 infection in 12 European residents: virus characteristics and disease progression. AIDS Lond Engl 1996; 10: 1649-1655.
94. Chauveau L, Puigdomenech I, Ayinde D, et al. HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells. Retrovirology 2015; 12: 2.
95. Yu H, Usmani SM, Borch A, et al. The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2- infected individuals. Retrovirology 2013; 10: 27.
96. Liovat A-S, Jacquelin B, Ploquin MJ, et al. African non human primates infected by SIV -why don't they get sick? Lessons from studies on the early phase of nonpathogenic SIV infection. Curr HIV Res 2009; 7: 39-50.
97. Chahroudi A, Bosinger SE, Vanderford TH, et al. Natural SIV hosts: showing AIDS the door. Science 2012; 335: 1188-1193.
98. Mamede JI, SitbonM, Battini J-L, Courgnaud V. Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors. Retrovirology 2013; 10: 77.
99. Bosinger SE, Johnson ZP, Folkner KA, et al. Intact type I Interferon production and IRF7 function in sooty mangabeys. PLoS Pathog 2013; 9: e1003597.
100. Harris LD, Tabb B, Sodora DL, et al. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol 2010; 84: 7886-7891.
101. Jacquelin B, Mayau V, Targat B, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest 2009; 119: 3544-3555.
102. Kirchhoff F. Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution? Nat Rev Microbiol 2009; 7: 467-476.
103. Vinton C, Klatt NR, Harris LD, et al. CD4-like immunological function by CD4-T cells in multiple natural hosts of simian immunodeficiency virus. J Virol 2011; 85: 8702-8708.
104. Sandler NG, Bosinger SE, Estes JD, et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 2014; 511: 601-605.